Exchange Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.23M Sell
1,064
-27
-2% -$31.9K 0.76% 38
2026
Q2
$1.31M Buy
1,091
+51
+5% +$52.1K 0.81% 35
2026
Q1
$957K Sell
1,040
-70
-6% -$71K 0.66% 43
2025
Q4
$1.19M Sell
1,110
-104
-9% -$99.4K 0.83% 34
2025
Q3
$926K Buy
1,214
+41
+3% +$30.5K 0.64% 44
2025
Q2
$914K Sell
1,173
-48
-4% -$37.3K 0.72% 40
2025
Q1
$1.01M Buy
1,221
+10
+0.8% +$8.32K 0.81% 36
2024
Q4
$935K Buy
1,211
+222
+22% +$184K 0.75% 38
2024
Q3
$876K Sell
989
-133
-12% -$120K 0.72% 41
2024
Q2
$1.02M Sell
1,122
-41
-4% -$32.8K 0.86% 36
2024
Q1
$905K Sell
1,163
-14
-1% -$10K 0.74% 38
2023
Q4
$686K Sell
1,177
-48
-4% -$28K 0.59% 48
2023
Q3
$658K Sell
1,225
-79
-6% -$40.7K 0.63% 46
2023
Q2
$612K Buy
+1,304
New +$547K 0.59% 47

Other funds holding LLY

Exchange Bank's LLY Position: Q3 2026 in Review

Exchange Bank reduced its Eli Lilly (LLY) stake by 2.5% in Q3 2026, selling an estimated $31.9K and leaving 1,064 shares worth $1.23M. The position accounts for 0.76% of the portfolio, ranked #38.

Exchange Bank first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.31M in Q2 2026. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Exchange Bank held 1,064 shares of Eli Lilly worth $1.23M as of Q3 2026.
  • Exchange Bank sold 27 Eli Lilly shares in Q3 2026, an estimated $31.9K.
  • Eli Lilly made up 0.76% of Exchange Bank's portfolio in Q3 2026, its #38 holding.
  • Exchange Bank first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
  • Exchange Bank's Eli Lilly position peaked at $1.31M in Q2 2026.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Exchange Bank's 13F filing for Q3 2026, filed 7 Oct 2026.